Table 2.

Outcomes of the cohorts before vs after implementation of the Vancouver 3M (multidisciplinary, multimodality, but minimalist) clinical pathway

Outcome	Pre-implementation (n = 126)	Post-implementation (n = 165)
30-day mortality	7 (5.6)	1 (0.6)
30-day rehospitalizations	36/119 (30)	11/164 (6.7)
In-hospital mortality	7 (5.5)	1 (0.6)
Requirement of second THV implantation	4 (3.2)	0 (0)
All vascular complications	14 (11)	3 (1.8)
Major vascular complications	3 (2.4)	0 (0)
PPM implantation	14/107 (13)	13/148 (8.8)
Post TAVI length of stay, d, median (IQR)	5 (2–6)	1 (1–3)

Values are n (%), unless otherwise specified.

IQR, interquartile range; PPM, permanent pacemaker; TAVI, transcatheter aortic valve implantation; THV, transcatheter heart valve.